InvestorsHub Logo
Followers 2
Posts 436
Boards Moderated 0
Alias Born 01/14/2014

Re: None

Monday, 09/04/2017 1:28:00 PM

Monday, September 04, 2017 1:28:00 PM

Post# of 807
The treatment, Kymriah, developed with British Aim-listed biotech Oxford BioMedica, is a one-time 'CAR-T' treatment that works by reprogramming white blood cells to kill cancer, in this first case a type of leukemia.

http://www.telegraph.co.uk/business/2017/09/04/novartis-follows-cancer-breakthrough-new-ceo/